⌘K

Home/Filings/4/0001209191-18-049112

4//SEC Filing

Bonner Michael 4

Accession 0001209191-18-049112

CIK 0001087294other

View on SEC.gov Company Profile

Filed

Aug 30, 8:00 PM ET

Accepted

Aug 31, 5:19 PM ET

Size

6.0 KB

Accession

0001209191-18-049112

Insider Transaction Report

Form 4

Period: 2018-08-28

CUMBERLAND PHARMACEUTICALS INCCPIX

Chief Financial Officer

Transactions

Purchase
Common Stock
2018-08-28$5.92/sh+300$1,776→ 18,354 total
Purchase
Common Stock
2018-08-29$6.24/sh+100$624→ 18,454 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001666790

Filing Metadata

Form type: 4
Filed: Aug 30, 8:00 PM ET
Accepted: Aug 31, 5:19 PM ET
Size: 6.0 KB

View on SEC.gov